Quantum Biopharma (QNTM) Free Cash Flow (QoQ) (2019 - 2026)

Quantum Biopharma (QNTM) Free Cash Flow (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Quantum Biopharma 13.00 Bn 13.00 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 523.27%
Dec 31, 2025 63.47%
Sep 30, 2025 -66.64%
Jun 30, 2025 65.63%
Mar 31, 2025 66.19%
Dec 31, 2024 -162,245.82%
Sep 30, 2024 100.44%
Jun 30, 2024 68.91%
Mar 31, 2024 -162.09%
Dec 31, 2023 -200.00%
Dec 31, 2022 -764.29%
Sep 30, 2022 -19.04%
Jun 30, 2022 84.09%
Mar 31, 2022 114.40%
Dec 31, 2021 -881.46%
Sep 30, 2021 -31.06%
Jun 30, 2021 32.09%
Sep 30, 2020 -5.27%
Jun 30, 2020 -18.91%
Jun 30, 2019 -69.83%